The Takeda Innovators in Science Award will recognize and celebrate disruptive and transformative research conducted by promising early career scientists and outstanding senior scientists across the globe in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology.
"As Takeda continues to embrace innovative science and thinking within our own organization, we look outward to honor those who are leading the way as an inspiration in our pursuit. We are privileged to partner with The New York Academy of Sciences to create the Takeda Innovators in Science Award, and look forward to recognizing and supporting the awardees' contributions to transformative research."
— Andrew Plump, MD, PhD
Chief Medical and Scientific Officer
Takeda Pharmaceutical Company Limited
"As the New York Academy of Sciences enters its Third Century of Innovation, the Takeda Innovators in Science Award will serve as an iconic example of our long-standing tradition of partnering with prestigious global partners to advance science and address the challenges confronting our planet. So we are delighted to call Takeda partners in the drive to improve human health through innovation."
— Ellis Rubinstein
President and Chief Executive Officer
The New York Academy of Sciences
- Two prizes of US $200,000 will be awarded each year. The Takeda Innovators in Science Award will recognize a promising young scientist and an outstanding senior scientist's contributions to science and is intended to support their commitment to innovative research in one of the designated areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology.
- The New York Academy of Sciences will administer the award on behalf of Takeda. Prize winners and finalists will be selected by a panel of independently selected judges with expertise in these disciplines.
- Nomination Period: The nomination period for the inaugural Takeda Innovators in Science Award, will open in March 2017.
- Awardee Announcement: The Awards will be conferred at a formal ceremony in New York City each fall. The inaugural winners will be honored at an Awards Ceremony and Symposium at the New York Academy of Sciences in November 2017.
- Further details will be announced here in February 2017.
The Takeda Innovators in Science Award will be a limited submission competition in which top research universities and academic institutions around the globe with a well established record of scientific excellence will be invited to nominate their most promising young faculty and their most extraordinary senior faculty working in the selected therapeutic fields.
- Institutional Eligibility: Institutions eligible to nominate candidates will be announced here in February 2017. Self-nominations are not allowed.
- Nominee Eligibility: Detailed eligibility requirements for nominees will be announced here in February 2017.
- Nomination Guidelines and Instructions: Detailed nomination guidelines and online nomination instructions will be announced here in February 2017.
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology, central nervous system and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit www.takeda.com/news.
About the New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been driving innovative solutions to society's challenges by advancing scientific research, education, and policy. With more than 20,000 members in 100 countries, the Academy is creating a global community of science for the benefit of humanity. Please visit us online at www.nyas.org and follow us on Twitter at @NYASciences.
Brooke Grindlinger, PhD
Chief Scientific Officer
Scientific Programs & Blavatnik Awards